Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$468,958
-$1,412,738 QoQ
Shares Held
19,475
-57.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,799
of 2,821 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carmignac Gestion holds $7,062,469 across 3 Drug Manufacturers - General names. PFE ranks #3 (6.6% of the industry book) .
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $468,958 | 19,475 | Shares | Sole | 2026-08-13 | |
| 2023-03-31 | $1,881,696 | 46,120 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,610,165 | 70,456 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,450,381 | 33,144 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $62,886,114 | 1,199,430 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $137,032,446 | 2,646,947 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $114,280,646 | 1,935,320 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||